InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Tsuchimoto Kim R, Chief Financial Officer. Director active across 1 companies, notably Monopar Therapeutics. Aggregated, 10 reports have been published. Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
8,913 shares
Common Stock
SEC:0001654954-22-009136:0·
1,221 shares
Common Stock
SEC:0001654954-22-004489:0·
1,231 shares
Common Stock
SEC:0001654954-22-000128·
1,221 shares
Common Stock
SEC:0001654954-22-000127·
1,221 shares
Common Stock
SEC:0001654954-22-000127:0·
1,231 shares
Common Stock
SEC:0001654954-22-000128:0·
1,221 shares
Common Stock
SEC:0001654954-21-010719·
1,221 shares
Common Stock
SEC:0001654954-21-010719:0·
2,442 shares
Common Stock
SEC:0001654954-21-007597·
2,442 shares
Common Stock
SEC:0001654954-21-007597:0·
10 of 10 declarations
About Tsuchimoto Kim R
Kim R. Tsuchimoto is the Chief Financial Officer at Monopar Therapeutics. In this role, he is responsible for the financial management of the company, including financial planning and risk management. Tsuchimoto plays a key role in developing financial strategies that support growth and profitability. His expertise in finance and accounting is essential for ensuring transparency and compliance with financial regulations.
